)
Edge
Extra Everything: The Story of Chipotle
Chipotle's story from a single restaurant to a nationwide chain, through crisis and turnaround, built on one of the strongest models in the industry.
BioInvent International
BioInvent International (BINV) investor relations material
BioInvent International Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2026 earnings summary29 Apr, 2026
Executive summary
Focused on advancing BI-1808 (anti-TNFR2) and BI-1206 (anti-FcyRIIB) antibody programs for cancer therapy, with promising interim Phase 2a results in ovarian cancer and NHL.
Achieved a Phase 3 milestone for HMI-115 in endometriosis, triggering a €1 million payment.
Nominated two new board members to strengthen governance as pipeline matures.
Financial highlights
Net sales for Q1 2026 were SEK 13.4 million, down from SEK 22.1 million in Q1 2025.
Loss after tax was SEK -119.2 million, compared to SEK -116.6 million year-over-year.
Cash flow from operating activities was SEK -132.8 million, versus SEK -120.0 million in Q1 2025.
Liquid funds and current investments at period end were SEK 456.5 million, down from SEK 742.2 million.
Equity/assets ratio at period end was 82%, compared to 89% a year earlier.
Outlook and guidance
Additional data from BI-1808 in ovarian cancer to be presented at ASCO 2026.
Further data from BI-1808 in CTCL and BI-1206 triplet in NHL expected mid-2026.
First readout from BI-1206 with pembrolizumab in NSCLC and uveal melanoma anticipated in H2 2026.
Company financed into late Q1 2027, but future financing solutions are being evaluated.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from BioInvent International
- Lead immuno-oncology antibodies show strong efficacy, with pivotal data expected in 2026.BINV
Corporate presentation6 Mar 2026 - Lead programs advance with strong data; liquidity robust; major readouts expected in 2025.BINVQ3 20244 Mar 2026
- Six clinical programs advance, early efficacy data, and SEK 867.2M in funds support 2025 milestones.BINVQ4 20244 Mar 2026
- Lead programs BI-1206 and BI-1808 advance with strong data and robust financial position.BINVQ3 20254 Mar 2026
- Strong clinical and financial momentum with pivotal trial milestones expected in 2026–2027.BINVQ4 20252 Mar 2026
- Prioritizing 1206 and 1808, with key clinical data and solid cancer focus driving near-term growth.BINVInvesting in Life Science 202517 Dec 2025
- SEK 30M Exoma deal and strong phase 2a data drive momentum for key oncology programs.BINVStatus Update21 Nov 2025
- Phase 2 immuno-oncology assets show strong efficacy, with pivotal milestones expected by 2027.BINVJefferies London Healthcare Conference 202520 Nov 2025
- Lead immuno-oncology assets show strong efficacy, with pivotal trials and key data expected in 2024.BINVJefferies Global Healthcare Conference 202514 Nov 2025
Next BioInvent International earnings date
KOL event27 May, 2026
BioInvent International
Next BioInvent International earnings date
KOL event27 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Explore our global coverage